Skip to content

Hair Regrowth Following Partial Thickness Removal of SSCIS

Hair Regrowth Following Partial Thickness Stages in Mohs Micrographic Surgery of Squamous Cell Carcinoma in Situ: A Prospective Pilot Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07809191
Enrollment
15
Registered
2026-09-09
Start date
2026-09-01
Completion date
2028-07-17
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia, Squamous Cell Carcinoma in Situ, Squamous Cell Carcinoma (Skin)

Keywords

mohs micrographic surgery, partial thickness excision

Brief summary

Participants are being approached to participate in this study because they are undergoing surgery for a skin cancer known as squamous cell carcinoma in situ (SCCIS) on the scalp. Standard surgical techniques may remove deeper structures that contain hair follicles, which can result in permanent hair loss. This study evaluates whether a modified surgical technique, known as partial thickness excision, can preserve hair growth and improve cosmetic outcomes. Participation involves minimal risk beyond the standard risks of Mohs surgery. If patients choose to participate, their surgery will be performed using this technique, and photographs will be taken over time to evaluate hair regrowth and healing.

Interventions

PROCEDUREPartial Thickness Excision

Participants will receive excision of their squamous cell carcinoma in situ of the scalp via partial thickness excision (removal of epidermal and superficial dermal tissue) in an effort to preserve hair follicles and hair growth potential.

Sponsors

The Cooper Health System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥ 18 years old * Histologically confirmed SCCIS * Lesions located in the hair-bearing scalp * Ability to provide informed consent

Exclusion criteria

* Invasive, poorly differentiated, or high-risk SCC features (e.g., perineural invasion) * Recurrent SCC at the same site * Prior radiation therapy to the scalp * Scarring alopecia or active inflammatory scalp disease at the treatment site * Immunosuppression that, in the investigator's judgement, increases oncologic risk * Use of topical minoxidil, oral minoxidil, finasteride, spironolactone, or other hair-growth promoting agents

Design outcomes

Primary

MeasureTime frameDescription
Hair Growth measured clinically by hair density percentage compared to baseline photo3 and 6 months post-procedure.To evaluate hair growth following partial thickness excision of SCCIS at 3 and 6 months post-procedure.

Secondary

MeasureTime frameDescription
Clearance of SCCIS measured by Mohs surgeons' interpretation of margins on surgical slides.Immediately following the final Mohs stage during the index procedureTo assess clinical and histologic clearance of SCCIS treated with partial-thickness excision.
Patient Satisfaction measured via patient satisfaction questionnaire3 and 6 months post-procedureTo evaluate patient-reported satisfaction with hair density and cosmetic outcome. "Are you satisfied with amount of hair//appearance of skin/result of treatment?" etc. on scale of 1-10. 1 being not satisfied and 10 being very satisfied/.
Complications2 weeks post-procedure, 3 months post-procedure, and 6 months post-procedureTo document wound-healing, complications, and the need for additional treatment.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026